¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Xiphophorus melanoma receptor kinase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® receptor ÇÑ±Û ¼ö¿ëü
¼³¸í   
  ¼¼Æ÷Áú³» ¶Ç´Â ¼¼Æ÷Ç¥¸é¿¡ Á¸ÀçÇϴ ºÐÀÚ±¸Á¶·Î¼­ Æ¯À̹°Áú°ú ¼±ÅÃÀûÀ¸·Î °áÇÕÇϸ砰áÇÕ¿¡ ÀÇÇØ Æ¯ÀÌÇÑ »ý¸®Àû ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. ÆéƼµåÈ£¸£¸ó, ½Å°æÀü´Þ¹°Áú, Ç׿ø, º¸Ã¼, ¸é¿ª±Û·ÎºÒ¸°¿¡ ´ëÇÑ ¼¼Æ÷Ç¥¸é ¼ö¿ëü¿Í ½ºÅ×·ÎÀ̵忡 ´ëÇÑ ¼¼Æ÷Áú³» ¼ö¿ëü°¡ ÀÖ´Ù.
¿µ¹® malignant melanoma ÇÑ±Û ¾Ç¼ºÈæ»öÁ¾
¼³¸í   
  ÇǺο¡¼­ »ý±â´Â ¾ÏÀÇ ÀÏÁ¾. ÁַΠ¹éÀο¡°Ô È£¹ßÇϸç, 50´ë~70´ë¿¡ ¸¹ÀÌ ¹ß»ýÇϰí, ÀþÀº ¿©¼º¿¡°Ô Áõ°¡Çϴ °æÇâÀÌ ÀÖÀ¸¸ç, ÇǺξÏÁß 1~3%¸¦ Â÷ÁöÇϴ µå¹® º´À¸·Î ÇǺο͠±âŸ ±â°üÀÇ ¸á¶ó´Ñ ¼¼Æ÷°è¿¡¼­ À¯·¡Çϴ ¾Ç¼ºÁ¾¾çÀÌ´Ù.
  
  ¿øÀÎÀ¸·Î Àϱ¤³ëÃâ°ú Á÷Á¢ÀûÀΠ°ü°è°¡ ÀÖÀ¸¸ç °¡Á·Àû ¹ß»ýµµ º¼ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈ­È¿¼Ò
  • acral lentiginous melanoma
    ¸»´ÜÈæÀÚÈæ»öÁ¾
  • benign juvenile melanoma
    ¾ç¼º¼Ò¾ÆÈæ»öÁ¾
  • choroidal malignant melanoma
    ¸Æ¶ô¸·¾Ç¼ºÈæ»öÁ¾
  • desmoplastic melanoma
    ¼¶À¯Á¶Á÷Çü¼ºÈæ»öÁ¾
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • melanoma
    Èæ»öÁ¾, ¸á¶ó´ÑÁ¾
  • superficial spreading melanoma
    ¾èÀºÈ®»êÈæ»öÁ¾, Ç¥ÀçÈ®»êÈæ»öÁ¾
  • verrucous melanoma
    »ç¸¶±Í¸ð¾çÈæ»öÁ¾
  • adenylate kinase
    ¾Æµ¥´Ò»êŰ³ª¾ÆÁ¦
  • creatine kinase
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦
  • creatine kinase isoenzymes
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦µ¿Á¾È¿¼Ò
  • kinase
    1. Ű³ª¾ÆÁ¦ 2. Ȱ¼ºÈ¿¼Ò 3. ÀλêÈ­È¿¼Ò
  • mitogen-activated protein kinase
    ¹ÌÅä°ÕȰ¼ºÈ­´Ü¹éÁúŰ³ª¾ÆÁ¦
  • phosphorylase kinase
    Æ÷½ºÆ÷¸±¶ó¾ÆÁ¦Å°³ª¾ÆÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • kinase
    Ȱ¼ºÈ¿¼Ò, Ű³ª¾ÆÁ¦
  • melanoma
    Èæ»öÁ¾, ¸á¶ó´ÑÁ¾
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • receptor blocker
    ¼ö¿ëüÂ÷´ÜÁ¦
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor
    ¼ö¿ëü, ¼ö¿ë±â
  • antigen receptor
    Ç׿ø¼ö¿ëü
  • opiate receptor
    ¾ÆÆí¼ö¿ëü
  • sensory receptor
    °¨°¢¼ö¿ëü
  • receptor site
    ¼ö¿ëüºÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈ­È¿¼Ò
  • creatine kinase
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦
  • kinase
    Ȱ¼ºÈ¿¼Ò, Ű³ª¾ÆÁ¦
  • mitogen-activated protein kinase
    ºÐ¿­Á¦È°¼º´Ü¹éŰ³ª¾ÆÁ¦
  • protein kinase
    ´Ü¹éÁúŰ³ª¾ÆÁ¦
  • pyruvate kinase
    ÇÇ·çºó»ê¿°Å°³ª¾ÆÁ¦
  • acral lentiginous melanoma
    ¸»´ÜÈæÀÚÈæ»öÁ¾
  • balloon cell melanoma
    dz¼±¼¼Æ÷Èæ»öÁ¾
  • benign juvenile melanoma
    ¾ç¼º¿¬¼ÒÈæ»öÁ¾
  • desmoplastic melanoma
    °áÇÕÁ¶Á÷Çü¼ºÈæ»öÁ¾
  • leptomeningeal melanoma
    ¿¬¼ö¸·Èæ»öÁ¾
  • melanoma
    Èæ»öÁ¾, ¸á¶ó´ÑÁ¾
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • nevocytic melanoma
    ¸ð¹Ý¼¼Æ÷Èæ»öÁ¾
  • nonpigmented melanoma
    ¹«»ö¼ÒÈæ»öÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acral lentiginous melanoma in situ
    ¿øÀ§Ä¡ ¸»´Ü ÈæÀÚ¼ºÈæ»öÁ¾
  • heritable melanoma syndrome
    À¯Àü¼ºÈæ»öÁ¾ÁõÈıº
  • Creatine kinase
    Å©·¹¾ÆÆ¾ Ű³ªÁ¦
  • Kinase
    Ä«À̳×ÀÌÁî
  • adenyl kinase
    ¾Æµ¥´ÒŰ³ªÁ¦
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×ÀÌÁî, ¾Æµ¥´Ò·¹ÀÌÆ®Å°³ªÁ¦
  • phosphoglycerate kinase
    Æ÷½ºÆ÷±Û¸®¼¼·¹ÀÌÆ®Å°³ªÁ¦
  • phosphorylase kinase
    Æ÷½ºÆ÷¸±¶ó¾ÆÁ¦Å°³ª¾ÆÁ¦
  • pyruvate kinase
    ÇÇ·çºê»ê¿° Ű³ªÁ¦
  • A1 receptor
    A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • A2 receptor
    A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • CR1 => complement receptor 1
    º¸Ã¼¼ö¿ëü 1
  • CR2 => complement receptor 2
    º¸Ã¼¼ö¿ëü 2
  • CR3 => complement receptor 3
    º¸Ã¼¼ö¿ëü 3
  • CR4 => complement receptor 4
    º¸Ã¼¼ö¿ëü 4
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-ARK : beta-adrenergic receptor kinase
    º£Å¸-¾Æµå·¹³¯¸°(¼º)¼ö¿ëü ÀλêÈ­È¿¼Ò.
  • adenyl kinase
    ¾Æµ¥´ÒŰ³ªÁ¦
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×ÀÌÁî, ¾Æµ¥´Ò·¹ÀÌÆ®Å°³ªÁ¦
  • creatine kinase
    Å©·¹¾ÆÆ¾Å°³ªÁ¦
  • creatine kinase assay
    Å©·¹¾ÆÆ¾Å°³ªÁ¦ÃøÁ¤
  • creatine kinase isoenzyme
    Å©·¹¾ÆÆ¾Å°³ªÁ¦À̼ҿ£ÀÚÀÓ<µ¿È°È¿¼Ò
  • cyclic AMP-dependent kinase
    °í¸® AMP ÀÇÁ¸¼º Ű³ªÁ¦
  • kinase
    Ä«À̳×À̽º.
  • macro-creatine kinase
    ¸¶Å©·Î-Å©·¹¾ÆÆ¾ Ű³ªÁ¦
  • mitogen-activated protein kinase
    ¹ÌÅä°Õ Ȱ¼º ´Ü¹é ±Í³ªÁ¦(¡­ üÀàõ Ó±ÛÜ ¡­ )
  • myotonin-protein kinase
    ¹Ì¿ÀÅä´Ñ-´Ü¹é(Ó±ÛÜ) Ű³ªÁ¦
  • phosphoglycerate kinase
    Æ÷½ºÆ÷±Û¸®¼¼·¹ÀÌÆ®Å°³ªÁ¦
  • phosphorylase kinase
    Æ÷½ºÆ÷¸±¶ó¾ÆÁ¦Å°³ª¾ÆÁ¦
  • protein kinase
    ´Ü¹éÁú Ä«À̳×ÀÌÁî
  • protein kinase c
    ´Ü¹éÄ«À̳×À̽º(´Ü¹éŰ³ªÁ¦)C(Ó±ÛÜ¡­)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Receptor
    ¼ö¿ë±â
    [¿¾ ¿ë¾î] ¼ö¿ë±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ®Ä«À̳×À̽º
  • AMP-kinase
    AMPÄ«À̳×À̽º
  • cAMP-dependent protein kinase
    cAMPÀÇÁ¸(ëîðí) ´Ü¹éÁú(Ó±ÛÜòõ) Ȱ¼ºÈ­È¿¼Ò(üÀàõûùý£áÈ)
  • creatine kinase
    Å©·¹¾ÆÆ¾ Ä«À̳×À̽º
  • kinase
    Ä«À̳×À̽º
  • nucleoside diphosphate kinase
    ÀÌÀλê(ì£×òß«) ´©Å¬¸®¿À»çÀ̵å Ä«À̳×À̽º
  • nucleoside monophosphate kinase
    ÀÏÀλê(ìé×òß«) ´©Å¬¸®¿À»çÀ̵å Ä«À̳×À̽º
  • phosphorylase kinase
    Æ÷½ºÆ÷¸±·¹À̽ºÄ«À̳×À̽º
  • polynucleotide kinase
    Æú¸®´©Å¬·¹¿ÀŸÀ̵å Ä«À̳×À̽º
  • protein kinase
    "´Ü¹éÁú(Ó±ÛÜòõ) Ä«À̳×À̽º, ´Ü¹éÁú(Ó±ÛÜòõ) Ȱ¼ºÈ­È¿¼Ò(üÀàõûùý£áÈ)"
  • pyruvate kinase
    ÆÄÀÌ·çºê»ê(ß«) Ä«À̳×À̽º
  • synthase-phosphorylase kinase
    ½ÅÅ×À̽º-Æ÷½ºÆ÷¸±·¹À̽º Ä«À̳×À̽º
  • thymidine kinase
    ŸÀ̵̹ò Ä«À̳×À̽º
  • thymidylate kinase
    ŸÀ̵̹ô»ê(ß«) Ä«À̳×À̽º
  • adrenergic receptor
    ¾Æµå·¹³¯¸°ÀÛµ¿(íÂÔÑ) ¼ö¿ëü(áôé»ô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • melanoma
    Èæ»öÁ¾
  • receptor
    ¼ö¿ë±â, ¼ö¿ëü, °¨¼öü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MM macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle...
AK above knee; acetate kinase; adenosine kinase; adenylate kinase; artificial kidney
CK calf kidney; casein kinase; chicken kidney; cholecystokinin; choline kinase; contralateral knee; cre...
TK thymidine kinase; transketolase; triose-kinase; tyrosine kinase
ER efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAP-KKK MAP kinase kinase kinase
MAPKKK mitogen activated protein kinase kinase kinase
MEKK1 mitogen-activated protein kinase kinase kinase 1
ALM Acral lentiginous melanoma
A-Mel-3 Amelanotic melanoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adenosine kinase
    ¾Æµ¥³ë½Å Ä«À̳×À̽º
    ATP+adenosine=ADP+AMPÀÇ È­ÇйÝÀÀÀ» Ã˸ÅÇÏ´Â ÀüÀÌÈ¿¼ÒÀÇ ÇϳªÀÌ´Ù. ÀÌ ¹ÝÀÀÀº
  • adenyl kinase
    ¾Æµ¥´ÒŰ³ªÁ¦
  • adenylate kinase
    ¾Æµ¥´Ò·¹ÀÌÆ® Ä«À̳×À̽º
  • creatinaemia : excess of creatine in the blood.

    creatine kinase

    Å©·¹¾ÆÆ¾ Ű³ª¾ÆÁ¦
  • myotonin-protein kinase
    ¹Ì¿ÀÅä´Ñ-´Ü¹é Ű³ªÁ¦
  • nucleoside kinase
    ´ºÅ¬·¹¿À½Ãµå Ű³ª¾ÆÁ¦
    ´ºÅ¬·¹¿À½ÃµåÀÇ ATP¿¡ ÀÇÇÑ ÀλêÈ­¸¦ Ã˸ÅÇÏ´Â È¿¼Ò. ÀϹÝÀûÀ¸·Î ±âÁú ´ºÅ¬·¹¿ÀƼµåÀÇ ¿°±â¿Í ´ç ºÎºÐÀÇ ¾çÂÊÀ¸·Î ƯÀ̼ºÀ» °®´Â´Ù
  • acral lentiginous melanoma
    ¸»´Ü¼º ÈæÁ¡¾ç Èæ»öÁ¾
    1. »óÇdz» Áõ½ÄÇϰí ÀÖ´Â Á¾¾ç ¼¼Æ÷´Â ¾Ç¼º ÈæÀÚÈæ»öÁ¾°ú À¯»çÇÑ ¼Ò°ßÀ̳ª Ç¥ÇÇ Áõ½Ä°ú ¼öÁö»ó µ¹±â¸¦ Áö´Ñ Èæ»öÁ¾ ¼¼Æ÷µéÀÌ ´Ù¼ö °üÂûµÇ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. 2. ¼±´ÜºÎ »Ó¸¸ ¾Æ´Ï¶ó ¼Õ¹Ù´Ú, ¹ß¹Ù´Ú ÁÖÀ§ ¹× Á¡¸·¿¡µµ »ý±â¸ç ƯÈ÷ µ¿¾çÀο¡°Ô ºóµµ°¡ ³ô´Ù. ºñ±³Àû Àå±â°£ÀÇ ¹ÝÁ¡ ³»Áö´Â ¼ö §¯³ª µÇ´Â ¹Ý ÇüÅ·Π°üÂûµÇ´Â ºñħÀ±±â¸¦ °¡Áö¸ç ƯÈ÷ ¼Õ°¡¶ôÀ̳ª ¹ß°¡¶ô »çÀÌ¿¡ ¹ß»ýÇÏ´Â °æ¿ì¿¡´Â Àå±â°£ ¹ß°ßµÇÁö ¾Ê°í Áö³ª°¡±âµµ ÇÑ´Ù.
  • benign juvenile melanoma
    ¾ç¼º À¯³â¼º Èæ»öÁ¾
    ¾ç¼º, À¶±â¼ºÀÌ¸ç ´Ü´ÜÇϰí ÇÎÅ©»ö ³»Áö ÀÚÀû»öÀ» ¶í ±¸ÁøÀÌ¸ç ´ë°³ ¾à°£ ³«¼³ ¼³Ç¥¸éÀ» °®°í, ÀϹÝÀûÀ¸·Î ¾ó±¼ ƯÈ÷ »´¿¡ ¹ß»ýÇÏ¸ç »çÃá±â Àü¿¡ ¹ßº´ÇÏ´Â °æ¿ì°¡ ¸¹´Ù.
  • early melanoma
    Ãʱâ Èæ»öÁ¾
    ¸á¶ó´Ñ ¼¼Æ÷ÀÇ ¾Ç¼º Á¾¾ç¿¡ Ãʱ⠴ܰè. Á¾Á¾ ¾ç¼º ¸ð¹ÝÀ¸·Î ¿ÀÇØµÈ´Ù. ±¸°­¿¡¼­ °¡Àå ÈçÇÑ Èæ»öÁ¾Àº Ç¥Ãþ È®À强 Èæ»öÁ¾, °áÀý¼º Èæ»öÁ¾, ¸»´ÜÈæ»öÁ¾À¸·Î ³ª´µ¾îÁø´Ù. ¿¹Èİ¡ ³ª»Ú´Ù.
  • early nodular melanoma
    Ãʱ⠼ҰáÀý¼º Èæ»öÁ¾
  • heritable melanoma syndrome
    À¯Àü¼º Èæ»öÁ¾ ÁõÈıº
  • juvenile melanoma
    ¿¬¼Ò¼º Èæ»öÁ¾
  • lentigo maligna melanoma
    ¾Ç¼º Èæ»öÁ¾
    ¸á¶ó´Ñ ¼¼Æ÷¿¡¼­ À¯·¡µÈ ¾Ç¼º Á¾¾ç. ¼öÆò Áõ½Ä±âÀÇ Èæ»öÁ¾ÀÎ ¾à¼º ÈæÀÚÀÇ ¼öÁ÷ Áõ½Ä±â¿¡ ÇØ´çÇÑ´Ù. ¼öÆò Áõ½Ä±âÀÇ Èæ»öÁ¾À¸·Î¼­ Ư¡ÀûÀ¸·Î Á߳⠳»Áö ³ë³âÃþÀÇ ÇÞºµÀ» ¸¹ÀÌ ¹ÞÀº ¾Èº¯ºÎ¿¡ È£¹ßÇÑ´Ù.
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
    1. ¿ÜÀ½¿¡ »ý±â´Â °¡Àå Áß¿äÇÑ º´º¯ÀÎ Á¾¾çÀÇ ÀÏÁ¾À¸·Î ¿ÜÀ½ÀÇ ¾Ç¼º Èæ»öÁ¾Àº µå¹°°í, ¿©¼º¿¡¼­ °üÂûµÇ´Â Èæ»öÁ¾ÀÇ 2%°¡ ¿ÜÀ½¿¡¼­ ¹ß»ýÇÑ´Ù. 2. »ö¼Ò ¼¼Æ÷¿¡ »ý±ä ¾Ç¼º Á¾¾ç. 3. Ç¥ÇǼº Èæ»ö±¸¿Í ±× Àü±¸Ã¼·ÎºÎÅÍ ¹ß»ýÇÏ´Â ´ë´ÜÈ÷ ¾Ç¼ºÀÎ Á¾¾çÀÌ´Ù. ¸ðµç ¾Ç¼º Á¾¾ç Áß 1%°¡ ¾Ç¼º Èæ»öÁ¾ÀÌ´Ù. ÀÌÁß 90%´Â ¿ÜÇÇ¿¡ ³ªÅ¸³ª°í 10%´Â ÇǺΠ¿Ü¿¡ ³ªÅ¸³­´Ù. ¸ðµç ¾Ç¼º Èæ»öÁ¾ Áß 1%´Â ±¸°­ ³»¿¡¼­ ¹ß»ýÇÑ´Ù. ¹ß»ýÀ²ÀÌ Áõ°¡µÇ´Â °Íó·³ º¸ÀÌ´Â ÀÌ·± Á¾¾çÀÇ Æ¯È÷ ³ª»Û Á¡Àº ¸²ÇÁ ¼øÈ¯°ú Ç÷¾× ¼øÈ¯À» ÅëÇØ ºü¸£°Ô ÀüÀ̵Ǵ °ÍÀÌ´Ù.
  • malignany melanoma
    ¾Ç¼º Èæ»öÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
Xiphophorus melanoma receptor kinase <enzyme> Growth factor receptor protein with an extracellular ligand binding domain and an intracellular catalytic domain
Registry number: EC 2.7.1.-
Synonym: xmrk protein
(26 Jun 1999)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
leukocyte tyrosine kinase receptor tyrosine kinase <enzyme> May be receptor for pre-b lymphocyte growth or differentiation factor; aa sequence given in first source
Registry number: EC 2.7.1.-
Synonym: ltk receptor tyrosine kinase, ltk receptor tk, ltk protein, leukocyte tyrosine kinase (ltk)
(26 Jun 1999)
Xiphophorus test A rarely used test for androgenic activity, based upon the fact that androgens cause the development of the sword, a male structure, in female swordfish (Xiphophorus helleri)
Synonym: Xiphophorus test.
(05 Mar 2000)
MAP kinase kinase kinase <enzyme> From pc12 cells; reactivates map kinase kinase inactivated by protein phosphatase 2a by phosphorylation of serine residues; tak1 (tgf-beta-activated kinase 1) is a member of the mapkkk family; genbank ab006787 (mouse)
Registry number: EC 2.7.10.-
Synonym: mapkkk, tak1 mapkkk, ask1 (kinase), apoptosis signal-regulating kinase 1
(26 Jun 1999)
beta-adrenergic receptor kinase <enzyme> Cyclic-AMP protein kinase which specifically phosphorylates the agonist-occupied form of beta-adrenergic receptor
Registry number: EC 2.7.1.-
Synonym: beta-ar kinase, beta-adrenergic receptor kinase 1, g-protein-coupled receptor kinase 2, grk2 (kinase), beta-adrenergic receptor kinase 2, beta-ar kinase 2
(26 Jun 1999)
p60 tumour necrosis factor receptor-associated kinase <enzyme> Interacts with and causes phosphorylation of the cytoplasmic domain of the tnf receptor
Registry number: EC 2.7.10.-
Synonym: p60 tnf receptor-associated kinase, p60-trak
(26 Jun 1999)
GAP-1 receptor tyrosine kinase <enzyme> Similar to rasGTPase-activating proteins; inhibits signaling activity of let-60; amino acid sequence given in first source
Registry number: EC 2.7.1.-
Synonym: gap-1 gene product, gap-1 protein
(26 Jun 1999)
receptor protein-tyrosine kinase <enzyme> A catalytic protein-tyrosine kinase domain found on the cytoplasmic beta-portion of receptors. Many growth and differentiation factor receptors contain this domain. It is critical for the signal transduction pathways required for mitogenesis, transformation, and cell differentiation.
Registry number: EC 2.7.1.-
(12 Dec 1998)
receptor tyrosine kinase Class of membrane receptors that phosphorylate tyrosine residues. Many play significant roles in development or cell division.
Examples: insulin receptor family, c ros receptor, Drosophila sevenless, trk family.
(18 Nov 1997)
Cek4 receptor protein-tyrosine kinase <enzyme> Isolated from mouse and chicken.
Registry number: EC 2.7.1.-
Synonym: cek4 protein, cek4 eph receptor, eph receptor cek4
(26 Jun 1999)
PL7a receptor-tyrosine kinase <enzyme> A member of the eph receptor tyrosine kinase subfamily; shows 80% identity with myk-1; genbank l43622
Registry number: EC 2.7.1.-
Synonym: pl7a protein
(26 Jun 1999)
muscarinic receptor kinase <enzyme> Phosphorylates muscarinic acetylcholine receptors and beta-adrenergic receptors
Registry number: EC 2.7.-
Synonym: muscarinic acetylcholine receptor kinase, machr kinase
(26 Jun 1999)
S-receptor kinase <enzyme> Srk - s-receptor kinase; from brassica oleracea; amino acid sequence has been determined
Registry number: EC 2.7.1.-
Synonym: srk gene product
(26 Jun 1999)
insulin receptor protein-tyrosine kinase <enzyme> A catalytic protein-tyrosine kinase domain found on the cytoplasmic beta-portion of the insulin receptor.
Registry number: EC 2.7.1.-
(12 Dec 1998)
TCK receptor-tyrosine kinase <enzyme> A member of the eph receptor tyrosine kinase subfamily; expressed during xenopus development; shows 79% amino acid identity to hek2; genbank l43621
Registry number: EC 2.7.1.-
Synonym: tck protein
(26 Jun 1999)
TGF-beta receptor protein kinase <enzyme> Belongs to the receptor-type serine-threonine kinase subfamily; from chick embryo, related to type II receptor for tgf-beta; 502 aa residues, mw 56,766 da; aa sequence given in first source
Registry number: EC 2.7.1.-
Synonym: tgf-beta rpk, rpk-1, rpk-2
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • kinase
    Ű³ª¾ÆÁ¦(È¿¼ÒÀÇ ÀÏÁ¾)
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
  • melanoma
    Èæ»öÁ¾
  • receptor
    ¼ö¿ë±â;°¨°¢±â°ü;¼ö¿ëü
  • receptor site
    ¼¼Æ÷³» ¼ö¿ë ¿µ¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á